Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edwards Lifesciences (GB:0REN)
LSE:0REN
RESEARCH TOOLSreports
Holding GB:0REN?
Track your performance easily
| Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 1.39B | $ 1.60B | $ 1.53B | $ 1.48B | $ 1.53B |
| Gross Profit | $ 1.10B | $ 1.21B | $ 1.18B | $ 1.13B | $ 1.19B |
| EBIT | $ 371.10M | $ 392.90M | $ 314.30M | $ 424.20M | $ 329.40M |
| EBITDA | $ 418.10M | $ 439.10M | $ 351.00M | $ 468.10M | $ 372.40M |
| Net Income Common Stockholders | $ 366.30M | $ 351.90M | $ 369.90M | $ 384.90M | $ 307.10M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 1.99B | $ 1.70B | $ 1.64B | $ 1.86B | $ 1.51B |
| Total Assets | $ 10.10B | $ 9.74B | $ 9.36B | $ 9.37B | $ 9.00B |
| Total Debt | $ 693.00M | $ 699.20M | $ 694.90M | $ 691.10M | $ 684.50M |
| Net Debt | $ -1.30B | $ -998.40M | $ -949.60M | $ -1.17B | $ -824.80M |
| Total Liabilities | $ 2.59B | $ 2.55B | $ 2.64B | $ 2.64B | $ 2.44B |
| Stockholders Equity | $ 7.44B | $ 7.12B | $ 6.65B | $ 6.66B | $ 6.49B |
| Cash Flow | - | ||||
| Free Cash Flow | $ 286.10M | $ -138.80M | $ 8.80M | $ 356.20M | $ 12.60M |
| Operating Cash Flow | $ 371.50M | $ -53.50M | $ 110.40M | $ 411.50M | $ 60.50M |
| Investing Cash Flow | $ 124.80M | $ 63.10M | $ 40.30M | $ 89.00M | $ 43.30M |
| Financing Cash Flow | $ -96.60M | $ 61.70M | $ -413.20M | $ -143.30M | $ 52.10M |